Income Statement Ovation Science Inc. OTC Markets

Stocks

OVATF

CA69016D1087

Personal Products

Market Closed - OTC Markets 13:53:17 2026-04-21 EDT			5-day change	1st Jan Change
0.0350 ^USD	-27.39%		+366.67%	+18.64%

08-11	Ovation Science Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-25	Ovation Science Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

cae33a72f524856233bde.lK1JFULJtYkNrB37is3GgPB255JXd3SfewBFhGeYh7k.5MU8ZxSb37po_F6cvvW21KpDystjPRenAVYLzQTV9_fN3jxXcJ_h61jpRA

Published financial data: OVATION SCIENCE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	225K	138K	61.93K	113K	67.89K
Total Revenues	225K	138K	61.93K	113K	67.89K
Cost of Goods Sold, Total	883K	4.05K	18.67K	27.5K	28.09K
Gross Profit	-658K	134K	43.26K	85.72K	39.8K
Selling General & Admin Expenses, Total	775K	807K	699K	550K	570K
Provision for Bad Debts	-	52	61.29K	-	-
Stock-Based Compensation (IS)	-	-	37.7K	-	68.46K
R&D Expenses	83.07K	65.27K	8.79K	12.53K	-
Depreciation & Amortization - (IS)	8.02K	6.73K	3.24K	2.12K	-
Other Operating Expenses, Total	866K	880K	811K	565K	638K
Operating Income	-1.52M	-745K	-767K	-479K	-598K
Interest Expense, Total	-	-588	-31.08K	-49.93K	-50.36K
Interest And Investment Income	4.72K	3	-	-	-
Net Interest Expenses	4.72K	-585	-31.08K	-49.93K	-50.36K
Currency Exchange Gains (Loss)	-1.93K	-4.17K	343	-266	-
Other Non Operating Income (Expenses)	-130K	-43.88K	-30.76K	73.04K	17.28K
EBT, Excl. Unusual Items	-1.65M	-794K	-829K	-456K	-631K
Asset Writedown	-742K	-	-	-	-
Other Unusual Items	-	-	15.6K	-	-
EBT, Incl. Unusual Items	-2.39M	-794K	-813K	-456K	-631K
Earnings From Continuing Operations	-2.39M	-794K	-813K	-456K	-631K
Net Income to Company	-2.39M	-794K	-813K	-456K	-631K
Net Income - (IS)	-2.39M	-794K	-813K	-456K	-631K
Net Income to Common Incl Extra Items	-2.39M	-794K	-813K	-456K	-631K
Net Income to Common Excl. Extra Items	-2.39M	-794K	-813K	-456K	-631K
Per Share Items
Net EPS - Basic	-0.08	-0.03	-0.03	-0.01	-0.02
Basic EPS - Continuing Operations	-0.08	-0.03	-0.03	-0.01	-0.02
Basic Weighted Average Shares Outstanding	29.37M	29.37M	30.32M	34.98M	35.6M
Net EPS - Diluted	-0.08	-0.03	-0.03	-0.01	-0.02
Diluted EPS - Continuing Operations	-0.08	-0.03	-0.03	-0.01	-0.02
Diluted Weighted Average Shares Outstanding	29.37M	29.37M	30.32M	34.98M	35.6M
Normalized Basic EPS	-0.04	-0.02	-0.02	-0.01	-0.01
Normalized Diluted EPS	-0.04	-0.02	-0.02	-0.01	-0.01
Supplemental Items
EBITDA	-1.52M	-739K	-764K	-477K	-596K
EBITA	-1.52M	-745K	-767K	-479K	-598K
EBIT	-1.52M	-745K	-767K	-479K	-598K
EBITDAR	-1.49M	-695K	-619K	-380K	-
Total Revenues (As Reported)	225K	138K	61.93K	113K	67.89K
Normalized Net Income	-1.03M	-496K	-518K	-285K	-395K
Interest on Long-Term Debt	-	165	13.71K	24.3K	19.81K
Supplemental Operating Expense Items
Advertising Expense	33.72K	19.93K	14.13K	3.86K	1.76K
Selling and Marketing Expenses	33.72K	19.93K	14.13K	3.86K	1.76K
General and Administrative Expenses	741K	788K	685K	546K	568K
Research And Development Expense From Footnotes	83.07K	65.27K	8.79K	12.53K	-
Net Rental Expense, Total	24K	44.13K	145K	97.22K	-
Imputed Operating Lease Interest Expense	-	-	308K	168K	-
Imputed Operating Lease Depreciation	-	-	-163K	-71.23K	-
Stock-Based Comp., Other (Total)	-	-	37.7K	-	68.46K
Total Stock-Based Compensation	-	-	37.7K	-	68.46K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	648K	28.9K	48.85K	3.31K	72.29K
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	648K	28.9K	48.85K	3.31K	72.29K
Accounts Receivable, Total	78.78K	53.24K	3.02K	25.01K	4.55K
Other Receivables	15.16K	7.15K	2.05K	6.74K	5.97K
Total Receivables	93.95K	60.39K	5.08K	31.75K	10.53K
Inventory	4K	2.32K	17.24K	28.84K	-
Prepaid Expenses	12.68K	7.78K	3.52K	-	-
Total Current Assets	758K	99.38K	74.69K	63.9K	82.82K
Gross Property Plant And Equipment	30.43K	32.51K	-	-	-
Accumulated Depreciation	-18.72K	-27K	-	-	-
Net Property Plant And Equipment	11.71K	5.5K	2.2K	-	-
Other Intangibles, Total	-	-	-	-	-
Total Assets	770K	105K	76.89K	63.9K	82.82K
Liabilities
Accounts Payable, Total	23.56K	23.82K	56.34K	130K	142K
Accrued Expenses, Total	40.18K	123K	418K	738K	1.12M
Short-term Borrowings	-	23.07K	22.54K	20.68K	23.16K
Current Portion of Long-Term Debt	-	-	152K	248K	260K
Other Current Liabilities	-	-	62.52K	17.79K	-
Total Current Liabilities	63.74K	170K	711K	1.15M	1.54M
Long-Term Debt	-	18.06K	18.27K	-	-
Total Liabilities	63.74K	188K	729K	1.15M	1.54M
Common Stock, Total	4.28M	4.28M	4.46M	4.52M	4.59M
Retained Earnings	-4.98M	-5.78M	-6.59M	-7.05M	-7.68M
Comprehensive Income and Other	1.41M	1.42M	1.48M	1.43M	1.63M
Total Common Equity	706K	-82.95K	-652K	-1.09M	-1.46M
Total Equity	706K	-82.95K	-652K	-1.09M	-1.46M
Total Liabilities And Equity	770K	105K	76.89K	63.9K	82.82K
Supplemental Items
ECS Total Shares Outstanding on Filing Date	29.37M	29.37M	33.89M	35.24M	38.41M
ECS Total Common Shares Outstanding	29.37M	29.37M	33.89M	35.24M	38.41M
Book Value / Share	0.02	-0	-0.02	-0.03	-0.04
Tangible Book Value	706K	-82.95K	-652K	-1.09M	-1.46M
Tangible Book Value Per Share	0.02	-0	-0.02	-0.03	-0.04
Total Debt	0	41.14K	193K	268K	283K
Net Debt	-648K	12.23K	144K	265K	211K
Debt Equivalent Oper. Leases	192K	353K	1.16M	778K	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	-	2.32K	-	4.17K	-
Inventories - Finished Goods, Total	4K	-	17.24K	24.67K	-
Machinery, Total	30.43K	32.51K	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-2.39M	-794K	-813K	-456K	-631K
Depreciation & Amortization - CF	8.02K	6.73K	3.24K	2.12K	-
Depreciation & Amortization, Total	8.02K	6.73K	3.24K	2.12K	-
Asset Writedown & Restructuring Costs	742K	-	-	-	-
Stock-Based Compensation (CF)	-	-	37.7K	-	68.46K
Provision and Write-off of Bad Debts	-	52	61.29K	-	-
Other Operating Activities, Total	841K	-5.31K	55.33K	-43.53K	15.06K
Change In Accounts Receivable	-44.01K	36.16K	-5.08K	-26.67K	21.22K
Change In Inventories	37.46K	813	-25.76K	-11.59K	10.57K
Change In Accounts Payable	-79.53K	79.63K	346K	354K	440K
Change in Other Net Operating Assets	2.6K	5.17K	4.26K	3.52K	-
Cash from Operations	-886K	-671K	-336K	-179K	-76.44K
Capital Expenditure	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	1.16M	-	-	-	-
Cash from Investing	1.16M	-	-	-	-
Short Term Debt Issued, Total	-	27.24K	-	-	-
Long-Term Debt Issued, Total	-	20K	182K	65.66K	-
Total Debt Issued	-	47.24K	182K	65.66K	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-	-10K	-	-
Total Debt Repaid	-	-	-10K	-	-
Issuance of Common Stock	-	-	200K	67.63K	146K
Other Financing Activities, Total	-	-	-16K	-	-
Cash from Financing	-	47.24K	356K	133K	146K
Foreign Exchange Rate Adjustments	-4.88K	4.9K	-186	-	-1.06K
Net Change in Cash	267K	-619K	19.95K	-45.54K	68.98K
Supplemental Items
Levered Free Cash Flow	-183K	-336K	-23.7K	-13.77K	86.15K
Unlevered Free Cash Flow	-183K	-336K	-4.27K	17.44K	118K
Change In Net Working Capital	-761K	-123K	-434K	-315K	-423K
Net Debt Issued / Repaid	-	47.24K	172K	65.66K	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-47.38	-106.51	-527.61	-425.32	-509.64
Return on Total Capital	-49.96	-140.26	191.31	46.73	37.42
Return On Equity %	-125.51	-254.83	221.25	52.36	49.52
Return on Common Equity	-125.51	-254.83	221.25	52.36	49.52
Margin Analysis
Gross Profit Margin %	-292.67	97.07	69.86	75.71	58.63
SG&A Margin	344.55	584.47	1.13K	485.89	838.93
EBITDA Margin %	-674.15	-534.68	-1.23K	-421.25	-878.02
EBITA Margin %	-677.71	-539.55	-1.24K	-423.12	-881.14
EBIT Margin %	-677.71	-539.55	-1.24K	-423.12	-881.14
Income From Continuing Operations Margin %	-1.06K	-574.76	-1.31K	-402.95	-929.86
Net Income Margin %	-1.06K	-574.76	-1.31K	-402.95	-929.86
Net Avail. For Common Margin %	-1.06K	-574.76	-1.31K	-402.95	-929.86
Normalized Net Income Margin	-458.93	-359.22	-836.32	-251.84	-581.16
Levered Free Cash Flow Margin	-81.55	-243.51	-38.26	-12.16	126.9
Unlevered Free Cash Flow Margin	-81.55	-243.24	-6.9	15.4	173.26
Asset Turnover
Asset Turnover	0.11	0.32	0.68	1.61	0.93
Fixed Assets Turnover	14.22	16.05	16.08	-	-
Receivables Turnover (Average Receivables)	3.58	2.09	2.2	8.08	4.59
Inventory Turnover (Average Inventory)	1.98	1.28	1.91	1.19	-
Short Term Liquidity
Current Ratio	11.89	0.59	0.11	0.06	0.05
Quick Ratio	11.63	0.53	0.08	0.03	0.05
Operating Cash Flow to Current Liabilities	-13.9	-3.95	-0.47	-0.15	-0.05
Days Sales Outstanding (Average Receivables)	101.91	174.4	165.8	45.31	79.46
Days Outstanding Inventory (Average Inventory)	183.97	284.8	191.19	306.67	-
Average Days Payable Outstanding	25.38K	3.66K	435.38	873.86	-
Cash Conversion Cycle (Average Days)	-25.09K	-3.2K	-78.39	-521.87	-
Long Term Solvency
Total Debt/Equity	-	-49.59	-29.54	-24.62	-19.4
Total Debt / Total Capital	-	-98.37	-41.92	-32.66	-24.07
LT Debt/Equity	-	-21.78	-2.8	-	-
Long-Term Debt / Total Capital	-	-43.2	-3.98	-	-
Total Liabilities / Total Assets	8.28	179.09	948.12	1.81K	1.86K
EBIT / Interest Expense	-	-1.27K	-24.69	-9.59	-11.88
EBITDA / Interest Expense	-	-1.26K	-24.58	-9.55	-11.84
(EBITDA - Capex) / Interest Expense	-	-1.26K	-24.58	-9.55	-11.84
Total Debt / EBITDA	-	-0.06	-0.25	-0.56	-0.47
Net Debt / EBITDA	0.43	-0.02	-0.19	-0.56	-0.35
Total Debt / (EBITDA - Capex)	-	-0.06	-0.25	-0.56	-0.47
Net Debt / (EBITDA - Capex)	0.43	-0.02	-0.19	-0.56	-0.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-70.01	-38.58	-55.17	82.8	-40.04
Gross Profit, 1 Yr. Growth %	-226.41	-120.37	-67.74	98.12	-53.57
EBITDA, 1 Yr. Growth %	62.22	-51.29	3.43	-37.58	24.98
EBITA, 1 Yr. Growth %	61.59	-51.1	2.93	-37.56	24.87
EBIT, 1 Yr. Growth %	61.59	-51.1	2.93	-37.56	24.87
Earnings From Cont. Operations, 1 Yr. Growth %	102.03	-66.83	2.4	-43.9	38.37
Net Income, 1 Yr. Growth %	102.03	-66.83	2.4	-43.9	38.37
Normalized Net Income, 1 Yr. Growth %	45.85	-51.93	4.37	-44.95	38.37
Diluted EPS Before Extra, 1 Yr. Growth %	83.4	-66.83	-0.79	-51.37	35.96
Accounts Receivable, 1 Yr. Growth %	68.2	-32.42	-94.32	726.68	-81.8
Inventory, 1 Yr. Growth %	-99.55	-42.12	644.84	67.24	-
Net Property, Plant and Equip., 1 Yr. Growth %	-41.23	-52.99	-60.01	-	-
Total Assets, 1 Yr. Growth %	-76.32	-86.38	-26.69	-16.89	29.61
Tangible Book Value, 1 Yr. Growth %	-70.16	-111.75	686.12	67.22	33.81
Common Equity, 1 Yr. Growth %	-77.28	-111.75	686.12	67.22	33.81
Cash From Operations, 1 Yr. Growth %	-36.05	-24.27	-49.91	-46.78	-57.25
Levered Free Cash Flow, 1 Yr. Growth %	-82.17	83.39	-92.96	-41.89	-725.64
Unlevered Free Cash Flow, 1 Yr. Growth %	-82	83.19	-98.73	-508.1	574.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-13.75	-57.08	-47.53	-9.47	4.7
Gross Profit, 2 Yr. CAGR %	52.27	-49.26	-74.36	-20.05	-4.09
EBITDA, 2 Yr. CAGR %	34.85	-11.11	-29.02	-19.65	-11.67
EBITA, 2 Yr. CAGR %	35	-11.11	-29.06	-19.84	-11.7
EBIT, 2 Yr. CAGR %	35	-11.11	-29.06	-19.84	-11.7
Earnings From Cont. Operations, 2 Yr. CAGR %	69.22	-18.14	-41.72	-24.2	-11.89
Net Income, 2 Yr. CAGR %	69.22	-18.14	-41.72	-24.2	-11.89
Normalized Net Income, 2 Yr. CAGR %	40.57	-16.27	-29.17	-24.2	-12.72
Diluted EPS Before Extra, 2 Yr. CAGR %	25.56	-22	-42.63	-30.54	-18.69
Accounts Receivable, 2 Yr. CAGR %	29.97	6.62	-80.4	-31.47	22.67
Inventory, 2 Yr. CAGR %	-81.03	-94.89	107.62	252.94	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-36.09	-47.44	-56.64	-	-
Total Assets, 2 Yr. CAGR %	-35.31	-82.04	-68.4	-21.95	3.78
Tangible Book Value, 2 Yr. CAGR %	-9.95	-81.28	-3.9	262.56	49.58
Common Equity, 2 Yr. CAGR %	-30.87	-83.66	-3.9	262.56	49.58
Cash From Operations, 2 Yr. CAGR %	-3.59	-30.41	-38.41	-48.37	-52.31
Levered Free Cash Flow, 2 Yr. CAGR %	-48.08	-42.81	-64.06	-79.77	90.67
Unlevered Free Cash Flow, 2 Yr. CAGR %	-47.25	-42.57	-84.74	-77.22	424.66
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	32.63	-22.98	-56.45	-20.46	-21.09
Gross Profit, 3 Yr. CAGR %	99.84	-22.12	-56.37	-49.32	-33.3
EBITDA, 3 Yr. CAGR %	-	-3.96	-6.5	-32	-6.9
EBITA, 3 Yr. CAGR %	54.58	-3.77	-6.66	-32.02	-7.07
EBIT, 3 Yr. CAGR %	54.58	-3.77	-6.66	-32.02	-7.07
Earnings From Cont. Operations, 3 Yr. CAGR %	67.61	-1.7	-11.79	-42.45	-7.36
Net Income, 3 Yr. CAGR %	67.61	-1.7	-11.79	-42.45	-7.36
Normalized Net Income, 3 Yr. CAGR %	48.11	-1.7	-9.89	-34.88	-7.36
Diluted EPS Before Extra, 3 Yr. CAGR %	37.21	-19.43	-15.49	-45.71	-13.12
Accounts Receivable, 3 Yr. CAGR %	25.44	4.51	-59.88	-31.78	-55.95
Inventory, 3 Yr. CAGR %	-46.09	-72.48	-73.11	93.18	-
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-42.31	-52.02	-	-
Total Assets, 3 Yr. CAGR %	-34.38	-61.51	-71.3	-56.38	-7.57
Tangible Book Value, 3 Yr. CAGR %	-23.59	-54.33	-34.93	15.58	160.06
Common Equity, 3 Yr. CAGR %	-31.42	-61.71	-40.58	15.58	160.06
Cash From Operations, 3 Yr. CAGR %	32.25	-11.04	-37.63	-41.34	-51.52
Levered Free Cash Flow, 3 Yr. CAGR %	3.17	-20.93	-71.55	-57.82	-36.5
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.4	-20.12	-83.87	-54.36	-29.53
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	35.62	-8.47	-17.84	-38.15
Gross Profit, 5 Yr. CAGR %	-	34.82	-12.11	-21.3	-40.21
EBITDA, 5 Yr. CAGR %	-	-	-	-10.57	-8.61
EBITA, 5 Yr. CAGR %	-	43.47	13.2	-10.55	-8.71
EBIT, 5 Yr. CAGR %	-	43.47	13.2	-10.55	-8.71
Earnings From Cont. Operations, 5 Yr. CAGR %	-	39.99	9.85	-11.41	-11.83
Net Income, 5 Yr. CAGR %	-	39.99	9.85	-11.41	-11.83
Normalized Net Income, 5 Yr. CAGR %	-	39.99	10.27	-11.41	-11.03
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-14.79	-3.19	-24.08	-16.79
Accounts Receivable, 5 Yr. CAGR %	-	33.52	-40.31	-11.72	-37.26
Inventory, 5 Yr. CAGR %	-	-	-7.55	-23.65	-
Total Assets, 5 Yr. CAGR %	-	-34.93	-51.01	-48.93	-52
Tangible Book Value, 5 Yr. CAGR %	-	14.91	-16.25	4.6	-9.22
Common Equity, 5 Yr. CAGR %	-	-31.88	-21.51	-5.9	-14.04
Cash From Operations, 5 Yr. CAGR %	-	36.07	-2.58	-28.44	-43.98
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-32.33	-54.16	-39.1
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-50.24	-51.64	-35.07